FNY Investment Advisers’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,600
Closed -$3.72M 887
2026
Q1
$3.72M Buy
12,600
+12,500
+12,500% +$3.71M 1.63% 11
2025
Q4
$27K Buy
+100
New +$27.2K 0.01% 530
2025
Q2
Sell
-10,300
Closed -$2.73M 994
2025
Q1
$2.73M Sell
10,300
-6,200
-38% -$1.53M 1.67% 8
2024
Q4
$3.83M Buy
+16,500
New +$3.79M 1.98% 6
2024
Q3
Sell
-100
Closed -$19K 695
2024
Q2
$19K Hold
100
0.01% 304
2024
Q1
$21 Sell
100
-5,000
-98% -$1.05M 0.01% 360
2023
Q4
$1.07M Buy
+5,100
New +$1.09M 1.19% 18
2022
Q4
Sell
-122
Closed -$21K 543
2022
Q3
$21K Buy
122
+51
+72% +$10.1K 0.01% 303
2022
Q2
$14K Sell
71
-129
-65% -$27.3K 0.01% 370
2022
Q1
$47K Buy
+200
New +$47K 0.04% 254
2020
Q3
Sell
-401
Closed -$65K 502
2020
Q2
$65K Buy
+401
New +$71.9K 0.04% 193
2019
Q4
Sell
-1,421
Closed -$300K 849
2019
Q3
$300K Buy
+1,421
New +$297K 0.09% 122

Other funds holding CME

FNY Investment Advisers's CME Position: Q2 2026 in Review

FNY Investment Advisers sold out of CME Group (CME) in Q2 2026, closing a stake of 12,600 shares — an estimated $3.72M sold.

FNY Investment Advisers first reported a position in CME in Q3 2019 and held it in 12 quarters. The position peaked at $3.83M in Q4 2024. 670 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • FNY Investment Advisers reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 12,600 CME Group shares in Q2 2026, an estimated $3.72M.
  • FNY Investment Advisers first reported a position in CME Group in Q3 2019 and held it in 12 quarters.
  • FNY Investment Advisers's CME Group position peaked at $3.83M in Q4 2024.
  • 670 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.